UvA-DARE ( Digital Academic Repository ) Costimulatory molecules in human atherosclerotic plaques : an indication of antigen specific T lymphocyte activation
暂无分享,去创建一个
[1] F. Ramsdell,et al. Fas and FasL in the homeostatic regulation of immune responses. , 1995, Immunology today.
[2] M. Rekhter,et al. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. , 1995, The American journal of pathology.
[3] J. Witztum,et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[4] F. Nestle,et al. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. , 1995, Journal of immunology.
[5] G. Peltz,et al. Costimulatory signals can selectively modulate cytokine production by subsets of CD4+ T cells. , 1995, Journal of immunology.
[6] M. Rep,et al. Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+CD45RA-CD27- T cell subset contains specialized primed T cells. , 1995, Journal of immunology.
[7] R. Effros,et al. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: A possible cause for both in vivo and in vitro immunosenescence , 1994, Experimental Gerontology.
[8] T. Kipps,et al. Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis. , 1994, Arthritis and rheumatism.
[9] P. Linsley,et al. Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin diseases. , 1994, The Journal of investigative dermatology.
[10] G. Freeman,et al. Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. , 1994, Journal of immunology.
[11] P. Linsley,et al. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. , 1994, Journal of immunology.
[12] R. V. van Lier,et al. CD27: marker and mediator of T-cell activation? , 1994, Immunology today.
[13] M. Jenkins,et al. Surface proteins involved in T cell costimulation , 1994, Journal of leukocyte biology.
[14] R. Armitage. Tumor necrosis factor receptor superfamily members and their ligands. , 1994, Current opinion in immunology.
[15] A. Becker,et al. Specialized membrane contacts between immunocompetent cells in human atherosclerotic plaques. , 1994, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[16] R. V. van Lier,et al. CD70 represents the human ligand for CD27. , 1994, International immunology.
[17] G. Hansson,et al. Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.
[18] F. Nestle,et al. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. , 1994, Blood.
[19] J. Delabie,et al. In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study. , 1993, International immunology.
[20] L. Lanier,et al. Functional Expression of B7/BB1 on Activated , 1993 .
[21] G. Hansson. Immune and inflammatory mechanisms in the development of atherosclerosis. , 1993, British heart journal.
[22] C. Morimoto,et al. CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions. , 1992, Journal of immunology.
[23] A. Becker,et al. Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. , 1992, The American journal of pathology.
[24] J. Allison,et al. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.
[25] G. Hansson,et al. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[26] M. Jenkins,et al. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.
[27] G. Freeman,et al. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. , 1991, Cellular immunology.
[28] O. Majdic,et al. CD27 expression by a distinct subpopulation of human B lymphocytes , 1990, European journal of immunology.
[29] A. Becker,et al. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[30] J. J. van den Oord,et al. Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. , 1989, Journal of immunological methods.
[31] G. Hansson,et al. Immune mechanisms in atherosclerosis. , 1989, Arteriosclerosis.
[32] R. V. van Lier,et al. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. , 1987, Journal of immunology.